Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029742 · ClinicalTrials.gov registry record · NA
Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02029742 is a NA study that has completed, run by Columbia University. The registered enrollment target is 60 participants.
The verdict
NCT02029742, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The investigators propose that culturally aligned community-based interventions in our multi-ethnic sickle cell disease (SCD) population, augmented by task-focused communication technology, can improve self-managed adherence to hydroxyurea (HU) by decreasing barriers to use, supporting parent-youth partnerships for chronic disease self-management and reinforcing the behavior of daily medication use. Culturally aligned community health workers (CHW) are a well-established means to support chronic disease self-management by underserved families, in partnership with medical homes. CHWs can identify and address multiple barriers and reinforce developmentally appropriate self-management to help youth reach and maintain their best fetal hemoglobin (HbF) levels. However, this strategy alone may be insufficient to achieve daily HU adherence. The investigators therefore propose a feasibility trial to test the feasibility and acceptability of a structured intervention of CHW support to address existing barriers to improve HU use, augmented by daily cue-based parent and youth text message reminders, to efficiently extend CHW family support and reinforce family partnerships for self-management.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Community Health Worker (CHW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029742
The ClinicalTrials.gov registry entry for NCT02029742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT02029742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029742 about?
NCT02029742 is a clinical study titled "Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment: HABIT". The investigators propose that culturally aligned community-based interventions in our multi-ethnic sickle cell disease (SCD) population, augmented by task-focused communication technology, can improve self-managed adherence to hydroxyurea (HU) by decreasing barriers to use, supporting parent-youth ...
What is the current status of trial NCT02029742?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2013-09. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02029742?
The interventions under investigation include: Education (BEHAVIORAL), Community Health Worker (CHW) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02029742?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.